Novo Nordisk and BioGeneriX acquire assets of Neose Technologies - MarketLine Financial Deals

Novo Nordisk and BioGeneriX acquire assets of Neose Technologies

Novo Nordisk and BioGeneriX acquire assets of Neose Technologies - MarketLine Financial Deals
Novo Nordisk and BioGeneriX acquire assets of Neose Technologies
Published Jan 27, 2009
3 pages — Published Jan 27, 2009
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Neose Technologies, Inc., a US-based biopharmaceutical company focused on the development of protein drugs, has sold substantially all of its assets to Novo Nordisk A/S, a Denmark-based diabetes healthcare company, and BioGeneriX AG, a Germany-based pharmaceutical company engaged in the development of therapeutic multisource proteins.

  
Source:
Document ID
MA00027_080919
Country
Country
Country
Ticker
NOVO.B=DK
Ticker
NTEC=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Novo Nordisk and BioGeneriX acquire assets of Neose Technologies" Jan 27, 2009. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novo-Nordisk-and-BioGeneriX-acquire-assets-of-Neose-Technologies-2052-11>
  
APA:
MarketLine Financial Deals. (2009). Novo Nordisk and BioGeneriX acquire assets of Neose Technologies Jan 27, 2009. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Novo-Nordisk-and-BioGeneriX-acquire-assets-of-Neose-Technologies-2052-11>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.